CA
NZ
UK
AU
IND
US
Dakota Gold Corp. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing a net loss of $8,349,808 for the second quarter and reporting cash and cash equivalents of $99,296,041 as of that date.
Corey Neil Riley, Chief Investment Officer and Chief Compliance Officer of Riley Exploration Permian, Inc. (NYSE:REPX), filed a Form 4 on August 12, 2026, disclosing two open-market sales of common stock executed on August 10, 2026, under a pre-established Rule 10b5-1 trading plan.
An amended statement of changes in beneficial ownership was filed on August 12, 2026 by Danyl R. Freeman, Chief Human Resources Officer of Burke & Herbert Financial Services Corp. (NASDAQ:BHRB), correcting the number of shares withheld upon settlement of stock-settled stock appreciation rights exercised …
H. Charles Maddy III, President and Director of Burke & Herbert Financial Services Corp. (NASDAQ:BHRB), filed a Form 4/A on August 12, 2026, amending an original Form 4 dated June 29, 2026, to correct the number of shares issued upon settlement of stock-settled stock …
Brian E. Shore, Board Chairman and CEO of Park Aerospace Corp, filed a Form 4 on August 12, 2026, disclosing the exercise of stock options and same-day sales of common stock on August 10 and August 11, 2026.
Gary S. Guthart, a director of Intuitive Surgical Inc (NASDAQ:ISRG), filed a Form 4 on August 12, 2026, disclosing the sale of 10,000 shares of common stock on August 11, 2026, at a price of $400 per share.
Susan G. Rice, Senior Vice President of Global Human Resources at Entegris Inc., filed a Form 4 on August 12, 2026, disclosing the sale of 2,062 shares of common stock on August 11, 2026.
Juan Camilo Arjona Ferreira, Head of R&D and Chief Medical Officer of Organon & Co. (NYSE:OGN), filed a Form 4 on August 12, 2026, reporting the vesting of restricted stock units and a related share withholding transaction dated August 11, 2026.
Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd. (NASDAQ:DRTS), filed a Form 4 on August 12, 2026, disclosing transactions in ordinary shares dated August 11, 2026, made pursuant to a Rule 10b5-1 plan.
Cencora, Inc. filed a Form 8-K with the SEC on August 12, 2026, disclosing that certain Walgreens volume began moving outside the company beginning July 1, 2026, while reaffirming its adjusted diluted EPS guidance range for fiscal year 2026.
Please wait processing your request...